桡骨远端骨折治疗的观察性研究是否稳健?E值分析方法
该研究检索了2001年1月至2021年7月的观察性研究,比较不同桡骨远端骨折治疗方式的总并发症和主要并发症风险,并用E值评估证据对未测量混杂因素的稳健性。结果显示各治疗方式间并发症风险无显著差异,但多数比较的E值置信区间下限接近1,提示观察到的并发症频率可能受未测量混杂因素影响。
要点
- 不同桡骨远端骨折治疗方式的总并发症和主要并发症风险无显著差异。
- 各比较组总并发症和主要并发症频率的平均E值为3.1至5.8。
- E值置信区间下限接近1,提示观察性证据对未测量混杂因素不够稳健。
核心结论
- 不同桡骨远端骨折治疗方式的并发症频率无显著差异,但多数比较观察性研究的并发症频率对潜在未测量混杂因素不够稳健。
研究设计与样本
- 检索PubMed、Embase和SCOPUS从2001年1月至2021年7月发表的桡骨远端骨折观察性研究,最终检索于2021年7月31日进行,纳入36项比较性观察性研究。
主要发现
- 掌侧钢板与背侧钢板比较:总并发症平均RR为1.2(95%CI 0.4至3.9;p=0.74),主要并发症平均RR为1.8(95%CI 0.4至11.4;p=0.52),均无显著差异。
- 掌侧钢板与石膏固定比较:总并发症平均RR为1.2(95%CI 0.3至11.2;p=0.87),主要并发症平均RR为1.5(95%CI 0.3至14.9;p=0.74),均无显著差异。
- 掌侧钢板与外固定比较:总并发症平均RR为0.6(95%CI 0.2至2.2;p=0.33),主要并发症平均RR为0.8(95%CI 0.2至6.7;p=0.86),均无显著差异。
- 掌侧钢板与经皮克氏针固定比较:总并发症平均RR为0.6(95%CI 0.2至2.6;p=0.47),主要并发症平均RR为0.7(95%CI 0.2至4.0;p=0.67),均无显著差异。
- 各组总并发症和主要并发症频率的平均E值为3.1至5.8,但E值置信区间下限接近1,提示观察到的并发症频率可能受未测量混杂因素影响。
关键数值与推荐
- 掌侧钢板与背侧钢板比较:总并发症平均RR 1.2(95%CI 0.4至3.9;p=0.74),主要并发症平均RR 1.8(95%CI 0.4至11.4;p=0.52)。
- 掌侧钢板与石膏固定比较:总并发症平均RR 1.2(95%CI 0.3至11.2;p=0.87),主要并发症平均RR 1.5(95%CI 0.3至14.9;p=0.74)。
- 掌侧钢板与外固定比较:总并发症平均RR 0.6(95%CI 0.2至2.2;p=0.33),主要并发症平均RR 0.8(95%CI 0.2至6.7;p=0.86)。
- 掌侧钢板与经皮克氏针固定比较:总并发症平均RR 0.6(95%CI 0.2至2.6;p=0.47),主要并发症平均RR 0.7(95%CI 0.2至4.0;p=0.67)。
临床怎么用
- 作者认为,E值方法或其他类型敏感性分析应在手外科观察性研究中于个体研究层面实施,以促进对潜在未测量混杂因素的稳健性评估。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Reported complication frequencies after distal radius fracture (DRF) treatment vary widely in the literature and are based mostly on observational evidence. Whether that evidence is sufficiently robust to use in practice is controversial. The E-value is an innovative sensitivity analysis that quantitates the robustness of observational evidence against unmeasured confounders, whereby a greater E-value usually implies more robust evidence and vice versa; with DRF complications, this approach can help guide readers to a more confident interpretation of the available evidence. QUESTIONS/PURPOSES: In this study, we sought (1) to compare the complication frequencies among different DRF treatment modalities, and (2) to evaluate the robustness of these observational studies using the E-value as an index for unmeasured confounding. METHODS: We searched PubMed, Embase, and SCOPUS for observational studies on the management of DRFs that were published from January 2001 to July 2021 with the last database search performed on July 31, 2021. All articles that compared different DRF treatment modalities with reported complication frequencies were included to accurately capture the quality of the observational studies in research about DRF. Risk ratios (RRs) of the overall complication and major complication risks were calculated for each subgroup comparison: volar plating versus dorsal plating, casting, external fixation, and percutaneous K-wire fixation. The RRs and their corresponding lower limits of the 95% confidence intervals (CIs) were used to derive the E-values. E-values can have a minimum possible value of 1, which signifies that the treatment-outcome association is not strong and can readily be overturned by unmeasured confounders. By contrast, a large E-value means that the observed treatment-outcome association is robust against unmeasured confounders. We averaged RRs and E-values for the effect estimates and lower limits of CIs across studies in each treatment comparison group. We identified 36 comparative observational studies that met the inclusion criteria. Seven studies compared volar with dorsal plating techniques. Volar plating was also compared with casting (eight studies), external fixation (15 studies), and percutaneous K-wire fixation (six studies). RESULTS: Total and major complication risks did not differ among different DRF treatments. The mean RRs for total and major complications were 1.2 (95% CI 0.4 to 3.9; p = 0.74) and 1.8 (95% CI 0.4 to 11.4; p = 0.52) for the volar versus dorsal plating group; 1.2 (95% CI 0.3 to 11.2; p = 0.87) and 1.5 (95% CI 0.3 to 14.9; p = 0.74) for the volar plating versus casting group; 0.6 (95% CI 0.2 to 2.2; p = 0.33) and 0.8 (95% CI 0.2 to 6.7; p = 0.86) for the volar plating versus external fixation group; and 0.6 (95% CI 0.2 to 2.6; p = 0.47) and 0.7 (95% CI 0.2 to 4.0; p = 0.67) for the volar plating versus K-wire fixation group. The mean E-values for total and major complication frequencies for the between-group comparison ranged from 3.1 to 5.8; these were relatively large in the context of a known complication risk factor, such as high-energy impact (RR 3.2), suggesting a reasonable level of robustness against unmeasured confounding. However, the E-values for lower limits of CIs remained close to 1, which indicates the observed complication frequencies in these studies were likely to have been influenced by unmeasured confounders. CONCLUSION: Complication frequencies did not differ among different DRF treatment modalities, but the observed complication frequencies from most comparative observational studies were less robust against potential unmeasured confounders. The E-value method, or another type of sensitivity analysis, should be implemented in observational hand surgery research at the individual-study level to facilitate assessment of robustness against potential unmeasured confounders. LEVEL OF EVIDENCE: Level III, therapeutic study.
引用
- Wang CW, Chung WT, Baxter NB, et al. Are Observational Studies on Distal Radius Fracture Treatment Robust? An E-value Approach to Analysis. Clin Orthop Relat Res. 2023. PMID: 36728049. doi:10.1097/CORR.0000000000002528
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。